Mar 13 - Vetnosis Publishes Top 60 Active Pharmaceutical Ingredient(s)/Top 100 Global Brands report
Edinburgh,
UK - 1st March 2013 - Vetnosis
publishes a new multi-client study on the Top 60 Active Pharmaceutical
Ingredient(s)/Top 100 Global Brands and Exclusivity in animal health
This
new multi-client study is a "must-have" report for any organisation involved in
the discovery, development, manufacturing supply chain or marketing and
distribution of animal health products; any firm analysing or advising animal
health companies; or any company considering entering the animal health sector.
- If you want to know the Sales of the Top 60 Franchises and Products by Active Pharmaceutical Ingredient(s) you need this report
- If you want to know the Sales, Exclusivity Status and Generic Resilience of the Top 100 Global Brands you need this report
- If you want to know the Sales and Age Profile of the Top 10 companies' key brands you need this report
"Not
only have we identified and quantified the most important APIs and global
brands in animal health but we have also analysed their exclusivity status and
resilience to generics" commented Tim Evans, Managing Director.
"During
a period of declining novel pharmaceutical innovation and increasing generic
pressure, life-cycle management of global brand assets is ever more critical to the major animal health companies.
Our analysis of the Top 10 companies' global brands has highlighted their
dependence on brands first launched in the 1970s, 1980s and 1990s, which have
lost their exclusivity." he added.
The
48 page report delivers unique data, analysis and commentary in three parts.
Part A:
Top 60 Franchises and Products by Active Pharmaceutical Ingredient(s)
1. Top 60 Franchises by Active Pharmaceutical Ingredient(s)
2. Top 60 Products by Active Pharmaceutical Ingredient(s)
Part B: Top 50
Global Brand Franchises and Top 100 Global Brands
1. Top 50 Global Brand Franchises
2. Top 100 Global Brands and Loss of Exclusivity
3. Top 100 Global Brands and Generic Resilience
Part C: Top 10 Company Analysis
For
further information please visit https://www.vetnosis.com to download a Brochure and Table of Contents or contact Tim Evans.
Tim Evans
Managing Director
T: +44 (0)131 718 0772
Email: tim.evans@vetnosis.com